Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator agent. Its precise mechanism of action is not fully understood, but it is thought to exert a direct relaxant effect on vascular smooth muscle, leading to vasodilation.
## Primary Indications
* Treatment of peripheral vascular diseases such as intermittent claudication and Raynaud's phenomenon.
* Historically used to prevent premature labor (tocolysis), but is generally not recommended for this indication due to limited efficacy and potential maternal/fetal risks compared to other agents.
## Adult Dosing
* **Peripheral Vascular Disease:**
* Oral: 10 mg to 20 mg three to four times daily.
* The dose may be increased as needed, but doses above 20 mg per administration are generally not recommended.
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride.
## Dose Adjustments
No specific dose adjustments are recommended for renal or hepatic impairment based on available literature, but caution may be warranted in patients with severe disease.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Should not be administered immediately postpartum or if there is significant vaginal bleeding.
## Adverse Effects
* **Common:** Nausea, vomiting, dizziness, flushing, weakness, gastrointestinal upset.
* **Less Common:** Hypotension, tachycardia, drowsiness, abdominal distress, skin rash.
* **Rare:** Paradoxical bronchospasm in patients with asthma.
## Key Drug Interactions
* **Antihypertensives:** May potentiate the hypotensive effects of antihypertensive medications.
* **Epinephrine:** Isoxsuprine may block the vasoconstrictor and pressor effects of epinephrine.
## Monitoring
* Blood pressure and heart rate.
* Symptoms of peripheral vascular disease (e.g., claudication distance, pain).
* Signs of adverse effects.
## Clinical Pearls
* Onset of action is typically within 30 minutes to 1 hour, with peak effects occurring around 1 to 2 hours.
* Efficacy in peripheral vascular disease is variable and patient response should be assessed.
* Due to its limited efficacy and safety concerns, its use as a tocolytic agent is generally discouraged.
***
*This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information or a qualified healthcare provider for patient-specific guidance. Always verify current prescribing information and local protocols.*
